"Rob" Robert Myers
RPh, PhD
Clinical Assistant Professor
BMS
Compounding • Dosage Forms • Pharmaceutics • Pharmaceutical Development
Dr. Myers has a BS degree in Pharmacy, a MS degree in Pharmaceutical Chemistry and a PhD in Pharmaceutical Chemistry from the University of Kansas. He is licensed as a Registered Pharmacist in the state of Idaho. With experience in academic teaching, retail pharmacy, pharmacy compounding, regulatory affairs, and pharmaceutical development/manufacturing, Dr. Myers holds a unique view of pharmaceutical products, their development, and regulatory approval. His experience includes developing and evaluating a variety of drug products including: various ophthalmic products, inhalation solutions, sterile injections, suspensions, delayed release capsules, dry powder inhalers, and nasal sprays.
Dr. Myers has more than 25 years of experience in the pharmaceutical industry focused mainly on activities dealing with Chemistry, Manufacturing, and Controls (CMC) issues for IND, NDA, and ANDA submissions. His activities have been mainly focused on: pre-formulation, formulation, scale-up, process development, pharmaceutical product safety data sheets (SDS), health hazard assessments, regulatory submission authoring and project planning. He has interacted with the FDA on various CMC issues at various development stages in face-to-face meetings, telephone conferences, and written communications. Dr. Myers also has more than 12 years of experience working as a compounding pharmacist and is the co-owner of a 503B Outsourcing Facility.
He is an assistant professor in the Biomedical & Pharmaceutical Sciences Department. His teaching responsibilities include dosage form design, compounding, pharmaceutical calculations, pharmacokinetics, and portions of modules and Capstone. Dr. Myers also oversees the extemporaneous compounding lab.